Bieber T, Thyssen JP, Irvine AD, Tsunemi Y, et al. Early improvements in signs and symptoms predict clinical response to baricitinib in patients with moderate-to-severe atopic dermatitis. Clin Exp Dermatol 2023 Apr 10:llad129. doi: 10.1093.
PMID: 37032446